Expansion of MSDB’s scope of use and research and development into related technologies
First written in FY2016. 13 of 35 entries say "Restated". Latest entry: FY2026.
26 other companies' latest entry also says "Other".
- FY2026Full-year research and development expenses decreasedAnnual report
「Accordingly, total R&D expenses for the fiscal year amounted to ¥49.285 million.」
Although the company continues R&D into Kansei metadata, utilization technologies, MSDB and related technologies, R&D expenses decreased from ¥71.837 million in the previous fiscal year to ¥49.285 million. - FY2026-H1Interim R&D Expenses DeclinedAnnual report
「R&D activities during the interim accounting period amounted to ¥25.763 million.」
Although the company states that there have been no material changes in its R&D activities, it reported R&D expenses of ¥25.763 million for the interim accounting period, down from ¥39.180 million in the same interim period of the previous year. - FY2025Full-year research and development expenses decreasedAnnual report
「The company is engaged in developing Kansei metadata and technologies for its utilization, which are sources of its competitive strength, expanding the scope of MSDB use, and strengthening its database and researching related technologies to diversify its revenue model. Accordingly, total R&D expenses for the fiscal year amounted to ¥71.837 million.」
Although the company continues R&D into Kansei metadata, utilization technologies, MSDB and related technologies, R&D expenses decreased from ¥82.366 million in the previous fiscal year to ¥71.837 million. - FY2025-H1Research and development expenses decreased year on yearAnnual report
「R&D activities during the interim accounting period amounted to ¥39.180 million.」
Although the company continues its R&D activities, R&D expenses decreased from ¥39.350 million in the same interim period of the previous year to ¥39.180 million. - FY2024Full-year research and development expenses decreasedAnnual report
「Accordingly, total R&D expenses for the fiscal year amounted to ¥82.366 million.」
While continuing R&D into Kansei metadata, utilization technologies, MSDB and related technologies, R&D expenses decreased from ¥115.962 million in the previous fiscal year to ¥82.366 million. - FY2024-Q3Research and development expenses decreased year on yearAnnual report
「R&D activities during the cumulative third quarter amounted to ¥63.540 million.」
Although the company continues its R&D activities, R&D expenses decreased from ¥90.692 million in the same period of the previous year to ¥63.540 million. - FY2024-Q2Research and development expenses decreased year on yearAnnual report
「R&D activities during the cumulative second quarter amounted to ¥39.350 million.」
The company continues its R&D activities and reported R&D expenses of ¥39.350 million for the cumulative second quarter, down from ¥64.598 million in the same period of the previous year. - FY2024-Q1Research and development expenses decreased year on yearAnnual report
「R&D activities during the cumulative first quarter amounted to ¥19.668 million.」
Although the company continues its R&D activities, R&D expenses decreased from ¥37.551 million in the same period of the previous year to ¥19.668 million. - FY2023-Q3R&D expenses increased year on yearAnnual report
「Research and development expenses for the nine-month cumulative period were ¥90.692 million.」
R&D expenses for the cumulative third quarter amounted to ¥90.692 million, up from ¥87.119 million in the same period of the previous year. The company states that there have been no material changes in its R&D activities. - FY2023-Q2R&D expenses increased year on yearAnnual report
「Research and development expenses for the six-month cumulative period were ¥64.598 million.」
The company continued its research and development activities, and research and development expenses increased from ¥54.407 million in the same period of the previous year to ¥64.598 million. - FY2023-Q1R&D expenses increased year on yearAnnual report
「Research and development expenses for the three-month cumulative period were ¥37.551 million.」
The company continued research and development on MSDB, affective metadata, and related technologies. Research and development expenses for the three-month cumulative period were ¥37.551 million, up from ¥29.215 million in the same period of the previous year. - FY2022Full-year research and development expenses increasedAnnual report
「The company is working to develop affective metadata, a source of its competitive strength, and technologies for its use, as well as to strengthen its database and research related technologies to expand the scope of use of MSDB and diversify its revenue model. Accordingly, total research and development expenses for the fiscal year were ¥140.055 million.」
The company continued research and development on affective metadata, technologies for its use, MSDB, and related technologies. Research and development expenses increased from ¥113.571 million in the previous fiscal year to ¥140.055 million. - FY2022-Q3R&D expenses increased year on yearAnnual report
「Research and development expenses for the nine-month cumulative period were ¥87.119 million.」
The company continued its research and development activities, and research and development expenses for the nine-month cumulative period were ¥87.119 million, up from ¥80.652 million in the same period of the previous year. - FY2022-Q2R&D expenses increased year on yearAnnual report
「Research and development expenses for the six-month cumulative period were ¥54.407 million.」
The company continued its research and development activities, and research and development expenses increased from ¥53.080 million in the same period of the previous year to ¥54.407 million. - FY2022-Q1R&D expenses increased year on yearAnnual report
「Research and development expenses for the three-month cumulative period were ¥29.215 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the three-month cumulative period were ¥29.215 million, up from ¥27.777 million in the same period of the previous year. It states that there were no material changes in the status of research and development activities. - FY2021Full-year research and development expenses increasedAnnual report
「The company is working to develop affective metadata, a source of its competitive strength, and technologies for its use, as well as to strengthen its database and research related technologies to expand the scope of use of MSDB and diversify its revenue model. Accordingly, total research and development expenses for the fiscal year were ¥113.571 million.」
The company continued research and development on affective metadata, technologies for its use, MSDB, and related technologies. Research and development expenses increased from ¥90.640 million in the previous fiscal year to ¥113.571 million. - FY2021-Q3R&D expenses increased year on yearAnnual report
「Research and development expenses for the nine-month cumulative period were ¥80.652 million.」
The company continued its research and development activities, and research and development expenses for the nine-month cumulative period were ¥80.652 million, up from ¥70.575 million in the same period of the previous year. - FY2021-Q2RestatedAnnual report
「Research and development expenses for the six-month cumulative period were ¥53.080 million. There were no material changes in the status of the company's research and development activities during the six-month cumulative period.」
It states that research and development expenses for the six-month cumulative period were ¥53.080 million and that there were no material changes in the status of research and development activities. - FY2021-Q1RestatedAnnual report
「Research and development expenses for the three-month cumulative period were ¥27.777 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the three-month cumulative period were ¥27.777 million, and it states that there were no material changes in the status of research and development activities. - FY2020Research and development expenses decreased year on yearAnnual report
「Accordingly, total research and development expenses for the fiscal year were ¥90.640 million.」
While continuing to expand the scope of use of MSDB and research related technologies and new services, research and development expenses fell from ¥117.334 million in the previous fiscal year to ¥90.640 million. - FY2020-Q3New disclosure of the investment ratioAnnual report
「While the core business shifted further toward the data and technology licensing business as the company evolves its business model from development- and operations-based revenue toward licensing revenue for future growth, we continued to invest actively in research and development and data development, targeting approximately 25% of revenue.」
The company newly disclosed a policy of actively investing approximately 25% of revenue in research and development and data development. It also stated that research and development expenses for the nine-month cumulative period were ¥70.575 million. - FY2020-Q2RestatedAnnual report
「Research and development expenses for the six-month cumulative period were ¥47.202 million. There were no material changes in the status of the company's research and development activities during the six-month cumulative period.」
It states that cumulative research and development expenses were ¥47.202 million and that there were no material changes in the status of the activities. - FY2020-Q1RestatedAnnual report
「Research and development expenses for the three-month cumulative period were ¥25.362 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the three-month cumulative period were ¥25.362 million, and it states that there were no material changes in the status of research and development activities. - FY2019AdvancedAnnual report
「The company is working to strengthen its database and research related technologies to expand the scope of use of MSDB, a source of its competitive strength, and diversify its revenue model, as well as to conduct research for new services. Accordingly, total research and development expenses for the fiscal year were ¥117.334 million.」
The company continued to expand the scope of use of MSDB and research related technologies and new services. Research and development expenses increased from ¥86.928 million in the previous fiscal year to ¥117.334 million. - FY2019-Q3RestatedAnnual report
「Research and development expenses for the nine-month cumulative period were ¥87.491 million. There were no material changes in the status of the company's research and development activities during the nine-month cumulative period.」
Research and development expenses for the nine-month cumulative period were ¥87.491 million, and it states that there were no material changes in the status of research and development activities. - FY2019-Q2RestatedAnnual report
「Research and development expenses for the six-month cumulative period were ¥54.956 million. There were no material changes in the status of the company's research and development activities during the six-month cumulative period.」
Research and development expenses for the six-month cumulative period were ¥54.956 million, and it states that there were no material changes in the status of research and development activities. - FY2019-Q1RestatedAnnual report
「Research and development expenses for the three-month cumulative period were ¥27.294 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the three-month cumulative period were ¥27.294 million, and it states that there were no material changes in the status of research and development activities. - FY2018AdvancedAnnual report
「The company is working to strengthen its database and research related technologies to expand the scope of use of MSDB, a source of its competitive strength, and diversify its revenue model, as well as to conduct research for new services. Accordingly, total research and development expenses for the fiscal year were ¥86.928 million.」
The company continued to strengthen MSDB and research related technologies and new services. Total research and development expenses for the fiscal year were ¥86.928 million. - FY2018-Q3RestatedAnnual report
「Research and development expenses for the nine-month cumulative period were ¥63.155 million. There were no material changes in the status of the company's research and development activities during the nine-month cumulative period.」
Research and development expenses for the nine-month cumulative period were ¥63.155 million, and it states that there were no material changes in the status of research and development activities. - FY2018-Q2RestatedAnnual report
「Research and development expenses for the six-month cumulative period were ¥37.077 million. There were no material changes in the status of the company's research and development activities during the six-month cumulative period.」
Research and development expenses for the six-month cumulative period were ¥37.077 million, and it states that there were no material changes in the status of research and development activities. - FY2018-Q1RestatedAnnual report
「Research and development expenses for the three-month cumulative period were ¥15.289 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the three-month cumulative period were ¥15.289 million, and it states that there were no material changes in the status of research and development activities. - FY2017-Q3RestatedAnnual report
「Research and development expenses for the nine-month cumulative period were ¥37.695 million. There were no material changes in the status of the company's research and development activities during the nine-month cumulative period.」
Research and development expenses for the nine-month cumulative period were ¥37.695 million, and it states that there were no material changes in the status of research and development activities. - FY2017-Q2RestatedAnnual report
「Research and development expenses for the six-month cumulative period were ¥25.492 million. There were no material changes in the status of the company's research and development activities during the six-month cumulative period.」
Research and development expenses for the six-month cumulative period were ¥25.492 million, and it states that there were no material changes in the status of research and development activities. - FY2017-Q1RestatedAnnual report
「Research and development expenses for the three-month cumulative period were ¥15.520 million. There were no material changes in the status of the company's research and development activities during the three-month cumulative period.」
Research and development expenses for the quarter were ¥15.520 million, and it states that there were no material changes in the status of research and development activities. - FY2016First statedAnnual report
「The company is working to strengthen its database and research related technologies to expand the scope of use of MSDB, a source of its competitive strength, and diversify its revenue model, as well as to conduct research for new services. Accordingly, total research and development expenses for the fiscal year were ¥29.097 million.」
The company conducted research and development to strengthen MSDB, develop related technologies, and research new services. Total research and development expenses for the fiscal year were ¥29.097 million.